Pfizer vaccine meets criteria for success, FDA says

By David Hogberg

Published December 8, 2020 2:10pm ET

Add Washington Examiner on Google

Pfizer vaccine meets criteria for success, FDA says — President Trump signed into law the FDA Reauthorization Act of 2017 on Friday. It reauthorizes a program in which drug and device makers pay the FDA a fee for every new product application, and the agency uses that money to hire more people and speed up approvals. (AP Photo/Andrew Harnik, File) | Andrew Harnik

The Food and Drug Administration signaled Tuesday that it is likely to approve emergency use authorization for the Pfizer/BioNTech coronavirus vaccine.

In a detailed analysis released Tuesday morning, the FDA said that it could find “no specific safety concerns identified that would preclude issuance of an EUA.”

Print subscriber? Click here to login/register your account

Digital subscriber? Click here to login/register your account.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.

Tag:

COVID-19 FDA Featured Video Featured Video Homepage Health Pfizer Vaccines